Sanbactacef-XP 1.125 Injection
By Sanbactacef-XP
Rx
1 Injection in a Vial

Composition
Ceftriaxone(1000mg) + Tazobactum(125mg)

Manufacturer - Santo Formulations
Solan, Himachal Pradesh, India

Expires on or after
October, 2025

liver
When using Sanbactacef-XP 1.125 Injection, it's important to be cautious if you have severe liver disease. In such cases, the dosage of Sanbactacef-XP 1.125 Injection may need to be adjusted. It's crucial to consult your doctor before starting treatment with Sanbactacef-XP 1.125 Injection if you have severe liver disease. However, if you have mild to moderate liver disease, dose adjustment of Sanbactacef-XP 1.125 Injection is not typically recommended. Always follow your doctor's guidance and advice regarding the use of Sanbactacef-XP 1.125 Injection in relation to your liver health.

kidney
Limited data exists on the use of Sanbactacef-XP 1.125 Injection in people with kidney issues. It's recommended to seek advice from your doctor.

alcohol
When taking Sanbactacef-XP 1.125 Injection, it is safe to consume alcohol as it does not lead to any harmful effects.

driving
Sanbactacef-XP 1.125 Injection may reduce alertness and cause drowsiness or dizziness. It is advised not to drive if experiencing these symptoms.

pregnancy
Sanbactacef-XP 1.125 Injection is generally safe during pregnancy. Animal studies show minimal harm to the baby, but human studies are limited.

breastfeeding
Sanbactacef-XP 1.125 Injection should be used cautiously while breastfeeding. It is advised to temporarily stop breastfeeding until the mother's treatment is finished and the medicine is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹151
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024